Dan Deaton is an angel investor at Triangle Angel Partners (TAP) since 2011 and serves as Executive Director, Patient Experience and Innovation at AstraZeneca since 2022, as well as a member of the Board of Directors at Community Workforce Solutions since 2012. They earned a BSME from North Carolina State University (1992-1996), an MSME from North Carolina State University (1996-1998), and an MBA from the University of North Carolina at Chapel Hill Kenan-Flagler Business School (2003-2005).
This person is not in the org chart
This person is not in any teams
This person is not in any offices